Nanjing Vazyme Biotech Co Ltd (688105) — Financial Flexibility Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥91.13 Million (operating CF CN¥75.30 Million minus capex CN¥15.83 Million) represents 0% of total liabilities (CN¥1.17 Billion). Check Nanjing Vazyme Biotech Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Nanjing Vazyme Biotech Co Ltd across 9 annual periods. See Nanjing Vazyme Biotech Co Ltd (688105) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nanjing Vazyme Biotech Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Nanjing Vazyme Biotech Co Ltd. For the full company profile including market capitalisation, see Nanjing Vazyme Biotech Co Ltd (688105) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥280.54 Million | CN¥233.16 Million | CN¥1.24 Billion | ▲ +284.4% |
| 2024 | 0.06x | CN¥65.21 Million | CN¥-9.68 Million | CN¥1.11 Billion | ▼ -76.5% |
| 2023 | 0.25x | CN¥431.31 Million | CN¥198.40 Million | CN¥1.72 Billion | ▼ -79.4% |
| 2022 | 1.22x | CN¥1.70 Billion | CN¥735.17 Million | CN¥1.39 Billion | ▼ -33.4% |
| 2021 | 1.83x | CN¥878.76 Million | CN¥616.80 Million | CN¥479.83 Million | ▼ -46.5% |
| 2020 | 3.42x | CN¥956.10 Million | CN¥803.55 Million | CN¥279.28 Million | ▲ +1113.1% |
| 2019 | 0.28x | CN¥35.08 Million | CN¥15.20 Million | CN¥124.31 Million | ▼ -15.1% |
| 2018 | 0.33x | CN¥28.13 Million | CN¥-4.00 Million | CN¥84.67 Million | ▼ -16.5% |
| 2017 | 0.40x | CN¥14.96 Million | CN¥-3.86 Million | CN¥37.57 Million | — |